Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
15.1 USD | +0.67% | -0.66% | -51.77% |
Kurzporträt
Mitarbeiterzahl: 610
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40.45% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40.45% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Stephen Davis
CEO | Chief Executive Officer | 63 | 15.07.14 |
Mark Schneyer
DFI | Director of Finance/CFO | 50 | 28.05.20 |
Benir Ruano
CTO | Chief Tech/Sci/R&D Officer | - | 01.11.22 |
Sanjeev Pathak
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.21 |
Brendan Teehan
COO | Chief Operating Officer | 56 | 01.07.18 |
Ponni Subbiah
CTO | Chief Tech/Sci/R&D Officer | - | 01.10.19 |
- | - | ||
Kimberly Manhard
PRN | Corporate Officer/Principal | 64 | 30.01. |
Kevin Oliver
PRN | Corporate Officer/Principal | - | 10.07.23 |
Holly Valdiviez
SAM | Sales & Marketing | - | 01.04.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 11.12.15 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 25.11.15 |
Stephen Davis
CEO | Chief Executive Officer | 63 | 15.07.14 |
Don Soland
BRD | Director/Board Member | 65 | 20.03.15 |
Laura Brege
BRD | Director/Board Member | 66 | 01.05.08 |
Stephen Biggar
CHM | Chairman | 53 | 22.01.13 |
James Daly
BRD | Director/Board Member | 63 | 11.01.16 |
Director/Board Member | 66 | 29.09.20 | |
Adora Ndu
BRD | Director/Board Member | 43 | 10.10.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 165 220 884 | 164 419 918 ( 99,52 %) | 0 | 99,52 % |
Unternehmenskontakt
ACADIA Pharmaceuticals, Inc.
12830 El Camino Real Suite 400
92130-3331, San Diego
+858 558 2871
http://www.acadia.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-51.77% | 2.49 Mrd. | |
+43.36% | 54.63 Mrd. | |
-5.31% | 39.92 Mrd. | |
+14.75% | 26.86 Mrd. | |
-12.56% | 26.22 Mrd. | |
-22.45% | 18.78 Mrd. | |
+25.12% | 12.21 Mrd. | |
+0.04% | 12.16 Mrd. | |
+26.04% | 11.94 Mrd. | |
-11.83% | 10.74 Mrd. |
- Börse
- Aktien
- 603035 Aktie
- Unternehmen ACADIA Pharmaceuticals Inc.